[{"AccountsPayableCurrent_0_Q2_USD":12739000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2_Q2_USD":1228000.0,"ContractWithCustomerLiability_0_Q2_USD":126615000.0,"ContractWithCustomerAssetReclassifiedToReceivable_2_Q2_USD":3000000.0,"ContractWithCustomerAssetGrossCurrent_0_Q2_USD":1042000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":43281000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3409000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":126600000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1204000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":982000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-4191000.0,"MarketableSecurities_0_Q2_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2587000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":80000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_Q2_shares":501000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4321000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":2085000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":313000.0,"UnbilledReceivablesCurrent_0_Q2_USD":5000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":3807000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-817000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-2589000.0,"ProceedsFromSaleOfMachineryAndEquipment_2_Q2_USD":1426000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":691000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":664000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1045000.0,"InterestExpenseDebt_2_Q2_USD":47000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q2_shares":501000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":126535000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":945000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":1228000.0,"RestructuringCharges_2_Q2_USD":1524000.0,"RestructuringCharges_1_Q2_USD":699000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":230000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.11,"OperatingLeaseRightOfUseAsset_0_Q2_USD":14864000.0,"OperatingLeasePayments_2_Q2_USD":2700000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":20171000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3163000.0,"OperatingLeaseLiability_0_Q2_USD":23334000.0,"NumberOfOperatingSegments_2_Q2_item":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":7976000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2753000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":5323000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5389000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":5510000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":5470000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":6865000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":31310000.0,"InvestmentIncomeNet_2_Q2_USD":708000.0,"InvestmentIncomeNet_1_Q2_USD":62000.0,"FinanceLeaseLiability_0_Q2_USD":0.0,"DeferredFinanceCostsNoncurrentNet_0_Q2_USD":15000.0,"DeferredFinanceCostsCurrentNet_0_Q2_USD":470000.0,"DebtInstrumentConvertibleNumberOfEquityInstruments_2_Q2_USD":501000.0,"DebtInstrumentConvertibleNumberOfEquityInstruments_1_Q2_USD":501000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":null,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":null,"InterestExpenseDebt_1_Q2_USD":23000.0,"SubleaseIncome_2_Q2_USD":713000.0,"OperatingLeaseExpense_2_Q2_USD":2000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-24298000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5902000.0,"ProfitLoss_2_Q2_USD":-53386000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":97743000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6426000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":44000.0,"NetIncomeLoss_1_Q2_USD":-24298000.0,"NetIncomeLoss_2_Q2_USD":-53386000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-56508000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":1382000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":98407000.0,"LiabilitiesCurrent_0_Q2_USD":90879000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":269728000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1340854000.0,"Liabilities_0_Q2_USD":294251000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-7187000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2161000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18631000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9767000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.31,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.14,"CommonStockValue_0_Q2_USD":1745000.0,"CommonStockSharesOutstanding_0_Q2_shares":174540000.0,"CommonStockSharesIssued_0_Q2_shares":174540000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":219506000.0,"AssetsCurrent_0_Q2_USD":241371000.0,"Assets_0_Q2_USD":269728000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1001000.0,"StockholdersEquity_0_Q2_USD":-24523000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":174354000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":171055000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":28312000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":15025000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1314586000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":15363000.0,"OtherAssetsNoncurrent_0_Q2_USD":7591000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":645000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-92000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":106000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":130000.0,"ShareBasedCompensation_2_Q2_USD":6576000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":50329000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":22921000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"OperatingIncomeLoss_2_Q2_USD":-42172000.0,"OperatingIncomeLoss_1_Q2_USD":-18362000.0,"OperatingExpenses_2_Q2_USD":70484000.0,"OperatingExpenses_1_Q2_USD":33387000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":2832000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q2_pure":0.045,"ConvertibleNotesPayable_0_Q2_USD":2100000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-53386000.0,"VariableLeaseCost_2_Q2_USD":3400000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN, INC.","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]